FYI: The following was put in the PR the first tim
Post# of 148185
(Total Views: 403)
Posted On: 03/02/2020 9:32:27 AM
Re: Evil Rabbit #19905
FYI: The following was put in the PR the first time, in Jan 21, 2020, and haven't changed since. It is not in the PR sections of the PR.
Not saying they can't do it. Just saying that the did not add it this time.
So, I'd say it's just a matter of time.
Quote:
CytoDyn plans to seek FDA approval for leronlimab in combination therapy and plans to complete the filing of a Biologics License Application (BLA) in the first quarter of 2020 for that indicatio
Not saying they can't do it. Just saying that the did not add it this time.
Quote:
But to give you a all an observation, in one of the calls about a week ago or two..
Nader, for the first time said, we are better than Humira. Prior to that he always said, we could be the next Humira.
So, I'd say it's just a matter of time.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼